MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+18.74%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$845M
AUM Growth
+$845M
(+49%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
27.01%
Top 10 Holdings %
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19
Top Buys
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
American Healthcare REIT
AHR
|
$9.88M |
| 5 |
ODDITY Tech
ODD
|
$8.91M |
Top Sells
| 1 |
PG&E
PCG
|
$4.69M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.27M |
| 3 |
Structure Therapeutics
GPCR
|
$4.16M |
| 4 |
argenx
ARGX
|
$3.8M |
| 5 |
Las Vegas Sands
LVS
|
$3.69M |
Sector Composition
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 5.62% |
| 3 | Technology | 5.05% |
| 4 | Consumer Discretionary | 2.94% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Alight
ALIT
$2.05B
| $98.5K | 0.01% | +10,000 | New | +$98.5K |
|
102
Karyopharm Therapeutics
KPTI
$61.7M
| – | – | -132,435 | Closed | -$34.9K |
|
103
AN2 Therapeutics
ANTX
$30.1M
| – | – | -33,997 | Closed | -$697K |
|
|
104
argenx
ARGX
$43.6B
| – | – | -10,000 | Closed | -$3.8M |
|
105
Aura Biosciences
AURA
$389M
| – | – | -198,415 | Closed | -$1.76M |
|
|
BLUE
106
DELISTED
bluebird bio
BLUE
| – | – | -500,000 | Closed | -$690K |
|
107
89bio
ETNB
$1.34B
| – | – | -140,000 | Closed | -$1.56M |
|
108
Fluence Energy
FLNC
$969M
| – | – | -100,000 | Closed | -$2.39M |
|
109
HCI Group
HCI
$2.16B
| – | – | -19,790 | Closed | -$1.73M |
|
110
Klaviyo
KVYO
$9.73B
| – | – | -68,974 | Closed | -$1.92M |
|
|
111
Las Vegas Sands
LVS
$39.6B
| – | – | -75,000 | Closed | -$3.69M |
|
112
Myriad Genetics
MYGN
$593M
| – | – | -50,000 | Closed | -$957K |
|
|
113
PG&E
PCG
$33.6B
| – | – | -260,000 | Closed | -$4.69M |
|
114
PureCycle Technologies
PCT
$2.57B
| – | – | -11,754 | Closed | -$47.6K |
|
115
Permian Resources
PR
$10B
| – | – | -175,900 | Closed | -$2.39M |
|
116
Vivid Seats
SEAT
$115M
| – | – | -30,000 | Closed | -$190K |
|
117
Shattuck Labs
STTK
$47M
| – | – | -100,000 | Closed | -$713K |
|
|
SWTX
118
DELISTED
SpringWorks Therapeutics
SWTX
| – | – | -73,949 | Closed | -$2.7M |
|
119
Wave Life Sciences
WVE
$1.53B
| – | – | -103,300 | Closed | -$522K |
|
|
AMAM
120
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – | -207,500 | Closed | -$2.95M |
|